Gwenn S. Smith, Ph.D. is the Richman Professor of Psychiatry and Behavioral Sciences and Radiology and Radiological Sciences, Johns Hopkins University School of Medicine. She is Director of the Division of Geriatric Psychiatry and Neuropsychiatry. She completed her undergraduate training (B.A.) in Psychology at the University of Pennsylvania and her graduate training (Ph.D.) in Neuropsychology at the City University of New York. She completed post-doctoral training at the Aging and Dementia Research Center, Department of Psychiatry, New York University (NYU) and the Positron Emission Tomography (PET) Program, Brookhaven National Laboratory. She served as Assistant Professor at NYU and the University of Pittsburgh and then, as Associate Professor at the Albert Einstein College of Medicine. She was promoted to Professor at the Albert Einstein College of Medicine in 2004 and, appointed as Professor at the Johns Hopkins School of Medicine in 2008. Her research has focused on developing and applying in vivo brain imaging methods to understand the neurochemical mechanisms underlying mood and cognitive symptoms in late life and the response to drug and brain stimulation treatments. This work has focused on geriatric depression, mild cognitive impairment and Alzheimer’s disease, as well as schizophrenia, traumatic brain injury and Parkinson’s Disease. She has been supported by independent grant funding from the National Institute of Health since 1993, including an Independent Scientist Award (K02) from the National Institute of Mental Health (1998-2010). She is Associate Editor of the American Journal of Geriatric Psychiatry and was an Associate Editor of Neuropsychopharmacology (Neuropsychopharmacology Reviews). She has been a chartered member of two National Institute of Health study sections and the Board of Scientific Counselors for the National Institute on Drug Abuse, Intramural Research Program. She is a fellow of the American College of Neuropsychopharmacology (ACNP), a member of the Collegium Internationale Neuropsychopharmacologicum (CINP) and a founding member and past-president of the International College of Geriatric Psychoneuropharmacology (ICGP).